Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis

NCT07433335 is registered in ClinicalTrials.gov with SciRhom GmbH as lead sponsor.

NCT NCT07433335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07433335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
Lead sponsor
SciRhom GmbH
Phase
Phase 1
Overall status
Recruiting
Start date
April 7, 2026
Completion date
February 29, 2028
Enrollment
27 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis